For menopausal women, tirzepatide may have an edge over semaglutide because GIP receptors are found in adipose tissue and may directly influence fat metabolism beyond what GLP-1 alone can achieve
Add 20 l 5% SSA and centrifuge at 8,000 g for 10 min
Serious adverse outcomes are categorized according to FDA-defined criteria, including: mortality (DE), life-threatening conditions (LT), hospitalization (HO), disability (DS), congenital anomalies (CA), and other medically significant events (OT)
Additional reported effects include flushing, headache, transient increases in blood pressure, and injection-site reactions
Using subcritical water to obtain polyphenol-rich extracts with antimicrobial properties